|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities held to maturity, at amortized cost (fair value, 2022, $141,797; 2021, $33,617) | ||||||||||||||||||||
| Securities held to maturity, at amortized cost (net of allowance for credit losses, 2025, $87; 2024, $94) | ||||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||||
| Securities held to maturity, at amortized cost (net of allowance for credit losses, 2026, $65; 2025, $83) | ||||||||||||||||||||
| Restricted securities, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for credit losses, 2025, $14,735; 2024, $16,400 | ||||||||||||||||||||
| Loans, net of allowance for credit losses, 2026, $14,943; 2025, $14,719 | ||||||||||||||||||||
| Other real estate owned, net of valuation allowance, 2025, $0, 2024, $0 | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Noninterest-bearing demand deposits | ||||||||||||||||||||
| Savings and interest-bearing demand deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated debt, net of issuance cost | ||||||||||||||||||||
| Junior subordinated debt | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred stock, par value $1.25 per share; authorized 1,000,000 shares; none issued and outstanding | ||||||||||||||||||||
| Common stock, par value $1.25 per share; authorized 16,000,000 shares; issued and outstanding, 2026, 9,042,629 shares; 2025, 9,025,395 shares | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
